Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers

  • Bernicker, Eric H. (PI)
  • Darcourt, Jorge (CoI)
  • Heyne, Kirk (CoI)

Project: Federal Funding Agencies

Project Details

StatusActive
Effective start/end date5/6/165/6/41